Bellevue Life Sciences Acquisition Unit 

$3.36
8
+$0+0% Friday 20:55

Statistics

Day High
4
Day Low
3.36
52W High
13.71
52W Low
3.36
Volume
4,450
Avg. Volume
4,536
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20JanExpected
Q4 0
Q1 2022
Q3 2022
Q4 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Profitable
2021
2022
2023
0Revenue
404,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLACU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Show more...
CEO
Mr. Kuk Hyoun Hwang
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is Bellevue Life Sciences Acquisition Unit stock price today?
The current price of BLACU is $3.36 USD — it has increased by +0% in the past 24 hours. Watch Bellevue Life Sciences Acquisition Unit stock price performance more closely on the chart.
What is Bellevue Life Sciences Acquisition Unit stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bellevue Life Sciences Acquisition Unit stocks are traded under the ticker BLACU.
What were Bellevue Life Sciences Acquisition Unit earnings last quarter?
BLACU earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bellevue Life Sciences Acquisition Unit revenue for the last year?
Bellevue Life Sciences Acquisition Unit revenue for the last year amounts to 0 USD.
What is Bellevue Life Sciences Acquisition Unit net income for the last year?
BLACU net income for the last year is 404,000 USD.
In which sector is Bellevue Life Sciences Acquisition Unit located?
Bellevue Life Sciences Acquisition Unit operates in the Financials sector.
When did Bellevue Life Sciences Acquisition Unit complete a stock split?
The last stock split for Bellevue Life Sciences Acquisition Unit was on December 02, 2020 with a ratio of 150:1.
Where is Bellevue Life Sciences Acquisition Unit headquartered?
Bellevue Life Sciences Acquisition Unit is headquartered in Bellevue, US.